The Missouri Valley Cancer Consortium (MVCC) is a community-based research effort with the specific aim of providing quality cancer care and research opportunities to patients in their respective communities. This is accomplished primarily through a networking of physicians, hospitals, and community cancer clinics across Nebraska and Iowa who recognize the unique needs of people with cancer, and who are committed to providing cancer care that has an emphasis on research whereby patients may benefit from cutting-edge technology in the areas of cancer treatment, cancer control, and cancer prevention. The MVCC serves a catchment area of primarily Nebraska and Iowa, and through affiliation with nationally recognized research groups, clinical trials are offered for a wide variety of cancers. A unique ability to provide clinical trials for cancer prevention and cancer control enhances the quality of this vital research program. The MVCC has direct affiliation with the North Central Cancer Treatment Group, Eastern Cooperative Oncology Group, Radiation Therapy Oncology Group, National Surgical Adjuvant Breast and Bowel Project, Gynecologic Oncology Group, and Southwest Oncology Group, is a member of the CTSU, or Clinical Trials Support Unit of the NIH, receives funding to support the program through an NIH grant as a Community Clinical Oncology Program (CCOP), and serves a data base of well over 1800 patients who have enrolled in clinical research studies over the years through their own community medical programs affiliated with MVCC. The MVCC has a proven track record of producing quality research work from a deeply committed team of healthcare professionals. Efforts are now being focused on community awareness of the importance of clinical research participation through pathways of public education about cancer, along with cancer screening and cancer prevention programs. Strategies to include minority populations in these important programs are being utilized as well. The long-term objective of this vital research program is to provide cancer patients access to clinical trials in their community, to promote quality cancer care and education, and to produce research data that will ultimately benefit all cancer patients.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
5U10CA063849-13
Application #
7104200
Study Section
Special Emphasis Panel (ZCA1-SRRB-E (J1))
Program Officer
O'Mara, Ann M
Project Start
1994-09-30
Project End
2007-05-31
Budget Start
2006-08-14
Budget End
2007-05-31
Support Year
13
Fiscal Year
2006
Total Cost
$481,028
Indirect Cost
Name
Missouri Valley Cancer Consortium, Inc.
Department
Type
DUNS #
145080730
City
Omaha
State
NE
Country
United States
Zip Code
68106
Barton, Debra L; Sloan, Jeff A; Shuster, Lynne T et al. (2018) Evaluating the efficacy of vaginal dehydroepiandosterone for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (Alliance). Support Care Cancer 26:643-650
Liu, Xiaonan; Li, Jing; Schild, Steven E et al. (2017) Statins and Metformin Use Is Associated with Lower PSA Levels in Prostate Cancer Patients Presenting for Radiation Therapy. J Cancer Ther 8:73-85
Sio, Terence T; Atherton, Pamela J; Birckhead, Brandon J et al. (2016) Repeated measures analyses of dermatitis symptom evolution in breast cancer patients receiving radiotherapy in a phase 3 randomized trial of mometasone furoate vs placebo (N06C4 [alliance]). Support Care Cancer 24:3847-55
Liu, Xiaonan; Li, Jing; Wu, Teresa et al. (2016) Patient Specific Characteristics Are an Important Factor That Determines the Risk of Acute Grade ? 2 Rectal Toxicity in Patients Treated for Prostate Cancer with IMRT and Daily Image Guidance Based on Implanted Gold Markers. OMICS J Radiol 5:
Rule, William G; Foster, Nathan R; Meyers, Jeffrey P et al. (2015) Prophylactic cranial irradiation in elderly patients with small cell lung cancer: findings from a North Central Cancer Treatment Group pooled analysis. J Geriatr Oncol 6:119-26
Park, Haeseong; Qin, Rui; Smith, Thomas J et al. (2015) North Central Cancer Treatment Group N10C2 (Alliance): a double-blind placebo-controlled study of magnesium supplements to reduce menopausal hot flashes. Menopause 22:627-32
Van Loon, Katherine; Espinoza, Anne M; Fogelman, David R et al. (2014) Should combination chemotherapy serve as the backbone in clinical trials of advanced pancreatic cancer? A pooled analysis of phase II trials of gemcitabine-containing doublets plus bevacizumab. Pancreas 43:343-9
Dronca, Roxana S; Allred, Jacob B; Perez, Domingo G et al. (2014) Phase II study of temozolomide (TMZ) and everolimus (RAD001) therapy for metastatic melanoma: a North Central Cancer Treatment Group study, N0675. Am J Clin Oncol 37:369-76
Dy, Grace K; Molina, Julian R; Qi, Yingwei et al. (2014) NCCTG N0821 (Alliance): a phase II first-line study of pemetrexed, carboplatin, and bevacizumab in elderly patients with advanced nonsquamous non-small-cell lung cancer with good performance status. J Thorac Oncol 9:1146-53
Barton, Debra L; Thanarajasingam, Gita; Sloan, Jeff A et al. (2014) Phase III double-blind, placebo-controlled study of gabapentin for the prevention of delayed chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy, NCCTG N08C3 (Alliance). Cancer 120:3575-83

Showing the most recent 10 out of 138 publications